Performance of an individualized, subcutaneous, basal-bolus insulin regimen for the management of prednisolone-associated hyperglycemia in hospitalized patients: a proof-of-concept study.

BMJ Open Diabetes Res Care · 2025 · PMC12598994 · PMID 41213662

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep=0.07so close (0.05 < p ≤ 0.1)

Mean 24-hour POC glucose was 1.2 mmol/L lower in the individualized group; this difference did not reach statistical significance (p=0.07, figure 1A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.